Our latest blog walks through how the affinity and kinetics data in the EV‑A71 2A OpenBind release were produced - from target selection to large‑scale structure and binding measurements. https://loom.ly/gZY5ylY
#StructuralBiology #Biophysics #OpenScience #AI
New results from Genesis Molecular AI exploring Pearl on the #OpenBind benchmark.
Encouraging to see engagement on such a challenging system. Read the blog: www.genesis.ml/news/zero-sh...
www.genesis.ml
More strikingly, the zero-shot Pearl system surpasses all evaluated methods, both cofolding and redocking, at the more stringent RMSD < 1 Å threshold. We believe sub-angstrom accuracy is more relevant to real-world drug discovery, and the Pearl system achieves this on a majority of compounds.
OpenBind
OpenBind
The latest blog from #OpenBind introduces a new structure–affinity dataset for the EV‑A71 2A protease, alongside reference benchmarks and guidance on how the community can use and evaluate it across docking, co‑folding, and affinity prediction. https://loom.ly/6xPIRUc
#OpenScience #DrugDiscovery #AI
Heading to the OpenFold Summit in Barcelona? Come and meet the OpenBind team and learn more about our first data release.
Curious about #AI driven protein-ligand modelling and the role of #OpenBind?
If you’re at #DrugDiscoveryChemistry next week, come along to this session in the Generative AI & Predictive Modelling track to find out more.
https://loom.ly/6kqUfSE
#OpenBind announces its first data drop marking a major milestone for AI‑Enabled #DrugDiscovery! It’s the first initiative to generate open, AI‑ready datasets for protein–drug complexes, produced continuously & at industrial scale to enable the next generation of #AI models. https://loom.ly/eIrsqqg
OpenBind
Our latest blog takes a behind‑the‑scenes look at the experimental and structural biology work behind #OpenBind’s first data release - from protein production to crystallographic model building and refinement.
https://loom.ly/Ydcti7A
#StructuralBiology #Crystallography #OpenScience
OpenBind
The OpenBind consortium’s first release of experimental data marks a milestone in efforts to improve how artificial intelligence (AI) is used in drug discovery.
Find out more ⬇️
https://www.ox.ac.uk/news/2026-05-12-openbind-releases-first-open-dataset-and-ai-model-for-drug-discovery
OpenBind
📢 A milestone for AI-driven drug discovery
Researchers from the department, as part of the @openbind.bsky.social consortium, have helped release a major new open dataset and predictive AI model to strengthen the data foundations for AI in drug discovery.
Read more: https://tinyurl.com/2j9u44mw
OpenBind
Sovereign AI officially launched yesterday to put Britain at the forefront of #AI. Supporting #OpenBind in its foundation phase, the £8 million seed fund will enable datasets for protein-drug complexes at an industrial scale, specifically for #AI to speed up #DrugDiscovery. https://loom.ly/eHc59cA
OpenBind
University of Oxford
Sovereign AI. Launching Tonight.🇬🇧 | 16 comments on LinkedIn
